Filing Flows › Comparisons › ABBV vs NVS
AbbVie vs Novartis AG: ABBV and NVS compared
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $14.4B for Novartis AG (Q2 2026). AbbVie is growing faster (+10% against +2% a year earlier). AbbVie is more profitable, with an operating margin of 36.0% against 33.0%.
Where the money goes: ABBV and NVS
AbbVie (ABBV) · Q3 2026
AbbVie, Q3 2026: revenue $17.4B (+10% year over year), operating margin 36.0%, net earnings $4.2B, operating cash flow $7.6B. The chart follows the revenue to costs, profit and cash.
Novartis AG (NVS) · Q2 2026
Novartis AG, Q2 2026: revenue $14.4B (+2% year over year), operating margin 33.0%, net earnings $3.3B, operating cash flow $5.9B. The chart follows the revenue to costs, profit and cash.
| AbbVie (ABBV) | Novartis AG (NVS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $17.4B | $14.4B |
| Revenue growth, Y/Y | +10% | +2% |
| Operating margin | 36.0% | 33.0% |
| Net earnings | $4.2B | $3.3B |
| Net margin | 24.2% | 22.6% |
| Operating cash flow | $7.6B | $5.9B |
| Free cash flow | $7.3B | — |
| Market value | $516.2B | — |
| P/E | 50.1× | — |
| Analysts’ mean target | $310.65 | — |
Questions
Which is bigger, AbbVie or Novartis AG?
AbbVie is the larger company: $17.4B of revenue in its latest quarter (Q3 2026) against $14.4B for Novartis AG (Q2 2026).
Is AbbVie or Novartis AG growing faster?
AbbVie is growing faster (+10% against +2% a year earlier).
Which is more profitable, AbbVie or Novartis AG?
AbbVie is more profitable, with an operating margin of 36.0% against 33.0%.
More: AbbVie earnings · how AbbVie makes money · Novartis AG earnings · how Novartis AG makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 6-K filed Jul 21, 2026). Fiscal quarters can end on different dates. Not investment advice.